APi (APG) Beats Q2 Earnings and Revenue Estimates — Positive

APG   Zacks Investment Research — July 31, 2025

APi (APG) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.33 per share a year ago.

image for news APi (APG) Beats Q2 Earnings and Revenue Estimates

Janus Henderson Group plc (JHG) Q2 Earnings and Revenues Top Estimates — Positive

JHG   Zacks Investment Research — July 31, 2025

Janus Henderson Group plc (JHG) came out with quarterly earnings of $0.9 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.85 per share a year ago.

image for news Janus Henderson Group plc (JHG) Q2 Earnings and Revenues Top Estimates

Lincoln Electric Holdings (LECO) Tops Q2 Earnings and Revenue Estimates — Positive

LECO   Zacks Investment Research — July 31, 2025

Lincoln Electric Holdings (LECO) came out with quarterly earnings of $2.6 per share, beating the Zacks Consensus Estimate of $2.32 per share. This compares to earnings of $2.34 per share a year ago.

image for news Lincoln Electric Holdings (LECO) Tops Q2 Earnings and Revenue Estimates

MGP (MGPI) Q2 Earnings and Revenues Top Estimates — Positive

MGPI   Zacks Investment Research — July 31, 2025

MGP (MGPI) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $1.71 per share a year ago.

image for news MGP (MGPI) Q2 Earnings and Revenues Top Estimates

PPL (PPL) Q2 Earnings Miss Estimates — Negative

PPL   Zacks Investment Research — July 31, 2025

PPL (PPL) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.38 per share a year ago.

image for news PPL (PPL) Q2 Earnings Miss Estimates

Hilton Grand Vacations (HGV) Q2 Earnings and Revenues Lag Estimates — Negative

HGV   Zacks Investment Research — July 31, 2025

Hilton Grand Vacations (HGV) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.62 per share a year ago.

image for news Hilton Grand Vacations (HGV) Q2 Earnings and Revenues Lag Estimates

Southern Co. (SO) Q2 Earnings and Revenues Surpass Estimates — Positive

SO   Zacks Investment Research — July 31, 2025

Southern Co. (SO) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $1.09 per share a year ago.

image for news Southern Co. (SO) Q2 Earnings and Revenues Surpass Estimates

Is There More Upside For MSFT Stock? — Positive

MSFT   Forbes — July 31, 2025

Microsoft (NASDAQ:MSFT) delivered a strong Q4 performance, surpassing consensus estimates for earnings, sales, and its future outlook. This positive news has sent the stock up 8% in pre-market trading, extending its impressive rally of over 50% since its April low of around $350.

image for news Is There More Upside For MSFT Stock?

What's Happening With AEye Stock? — Positive

LIDR   Forbes — July 31, 2025

AEye stock (NASDAQ: LIDR) had a solid July, rising by close to 240% over the month, although the stock has retraced by about 12% over the last five trading days. AEye develops adaptive LiDAR (light detection and ranging) systems used to enable advanced driver-assistance systems (ADAS) and autonomous driving capabilities.

image for news What's Happening With AEye Stock?

Survey of over 6,000 U.S. and U.K. adults finds more optimistic outlook on personal finances than national economies, introduces new data on credit score awareness Survey of over 6,000 U.S. and U.K. adults finds more optimistic outlook on personal finances than national economies, introduces new data on credit score awareness

image for news Encore Capital Group® Announces Findings of its Third Economic Freedom Study

LOS ANGELES , July 31, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tempus AI, Inc. ("Tempus" or "the Company") (NASDAQ: TEM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and May 27, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 12, 2025.

image for news TEM Investors Have Opportunity to Lead Tempus AI, Inc. Securities Fraud Lawsuit with the Schall Law Firm

374Water achieves destruction of PFAS in biosolids with AirSCWO system — Positive

PWVI  SCWO   Proactive Investors — July 31, 2025

374Water Inc (NASDAQ:SCWO) announced that its commercial-scale AirSCWO (Air Supercritical Water Oxidation) system is capable of consistently destroying per- and polyfluoroalkyl substances (PFAS) in biosolids to non-detectable levels. The company's technology targets PFAS, a class of synthetic chemicals often referred to as “forever chemicals” due to their persistence in the environment.

image for news 374Water achieves destruction of PFAS in biosolids with AirSCWO system

Meta: Q2 Earnings Likely Just The Opening Act Of A Bull Run — Positive

META   Seeking Alpha — July 31, 2025

I don't expect to see Meta Platforms, Inc. trading below $750 anytime soon. Any pullback to this level could be a decent entry point for institutional funds that are uninvested. Meta's growth is relentless. Q2 DAUs hit 3.4 billion, and the family of apps' ad revenue is up 21% YOY, driven by improvements in AI recommendation algorithms. Meta raised FY 2025 CapEx lower range by $2B to $66B. The midpoint of the guidance represents a $30B YOY increase. The AI narrative remains intact.

image for news Meta: Q2 Earnings Likely Just The Opening Act Of A Bull Run

Does OptimizeRx Have a Moat in the Crowded HealthTech Space? — Neutral

OPRX   Zacks Investment Research — July 31, 2025

OptimizeRx OPRX is carving out a secure niche in the increasingly crowded HealthTech landscape, signaling a developing moat anchored in scale, data and execution. Over the previous two quarters, the company has posted double-digit top-line growth.

image for news Does OptimizeRx Have a Moat in the Crowded HealthTech Space?

FirstEnergy Q2 Earnings Surpass Estimates, Revenues Increase Y/Y — Neutral

FE   Zacks Investment Research — July 31, 2025

FE's second-quarter earnings and revenues increase year over year. Total operating expenses decrease during the same period.

image for news FirstEnergy Q2 Earnings Surpass Estimates, Revenues Increase Y/Y

Acadian Asset Management (AAMI) Q2 Earnings and Revenues Beat Estimates — Positive

AAMI   Zacks Investment Research — July 31, 2025

Acadian Asset Management (AAMI) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.45 per share a year ago.

image for news Acadian Asset Management (AAMI) Q2 Earnings and Revenues Beat Estimates

Allegheny Technologies (ATI) Q2 Earnings Beat Estimates — Positive

ATI   Zacks Investment Research — July 31, 2025

Allegheny Technologies (ATI) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.6 per share a year ago.

image for news Allegheny Technologies (ATI) Q2 Earnings Beat Estimates

Distribution Solutions Group (DSGR) Lags Q2 Earnings Estimates — Negative

DSGR   Zacks Investment Research — July 31, 2025

Distribution Solutions Group (DSGR) came out with quarterly earnings of $0.35 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.4 per share a year ago.

image for news Distribution Solutions Group (DSGR) Lags Q2 Earnings Estimates

Agco (AGCO) Q2 Earnings and Revenues Surpass Estimates — Positive

AGCO   Zacks Investment Research — July 31, 2025

Agco (AGCO) came out with quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $2.53 per share a year ago.

image for news Agco (AGCO) Q2 Earnings and Revenues Surpass Estimates

Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Misses Revenue Estimates — Negative

VNDA   Zacks Investment Research — July 31, 2025

Vanda Pharmaceuticals (VNDA) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $0.08 per share a year ago.

image for news Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Misses Revenue Estimates